Why is Anuh Pharma falling/rising?

As of 15-Sep, Anuh Pharma Ltd's stock price is currently at 88.47, reflecting an increase of 0.47 (0.53%). The stock has shown a positive trend recently, gaining 1.47% over the last two days and outperforming its sector by 0.98%. However, despite this recent uptick, the stock has underperformed over the longer term, with a year-to-date decline of 21.62% and a one-year return of -18.35%. The company has a low debt-to-equity ratio and an attractive return on equity of 14.2, indicating a fair valuation compared to peers. Nonetheless, the stock's profits have decreased by 20.2% over the past year, contributing to its overall negative performance. In the broader market context, Anuh Pharma's short-term return of 3.17% over the past week significantly outpaces the Sensex's gain of 1.24%. However, the stock's long-term performance remains concerning, as it has underperformed the market over the past year, where the BSE500 index fell by only 3.45%. The decline in investor participation, evidenced by a 35.44% drop in delivery volume, suggests waning interest, which may hinder any sustained recovery. Overall, while the stock has shown some positive movement recently, its long-term growth prospects and recent negative financial results continue to weigh heavily on investor sentiment.